Mass Spectrometry News
Native mass spectrometry is shown to be able to interrogate the pharmacology of the beta-1 adrenergic receptor, a G protein-coupled receptor, and has discovered the endogenous zinc ion as a positive allosteric modulator in well-studied receptor.
Shimadzu and Germany’s University Medical Center Göttingen are developing new clinical LC-MS methods for a more rapid and flexible therapeutic drug monitoring analysis.
A novel focusing quadrupole ion funnel takes advantage of RF ion focusing technology in proton transfer reaction mass spectrometry and greatly improves its sensitivity.
Liquid chromatography-mass spectrometry and an electrochemical flow cell could spark a “paradigm shift” in biopharmaceuticals testing.
A new method to detect Parkinson’s disease has been determined by analysing sebum with paper spray mass spectrometry.
Mass spectrometry imaging provides highly precise information on the spatial distribution of substances. Researchers at the University of Bayreuth have succeeded in making visible an additive in dairy products and a production-related contamination in baked goods.
Native ambient mass spectrometry can analyse how drug molecules bind to proteins in tissue samples and could offer an improved route to drug discovery and development.
Thermo Fisher Scientific and TransMIT GmbH Center for Mass Spectrometric Developments have announced a co-marketing agreement to promote the use of a mass spectrometry imaging (MSI) platform for spatial multi-omics applications in pharma and clinical labs.
The Gordon F. Kirkbright and Edward Steers awards are seeking nominations.
GC-MS “fingerprints” of sesquiterpene hydrocarbons have proved to be excellent markers for the geographic origin of olive oil.
The first local managing director for Shimadzu Denmark, Joachim Holm, has been appointed.
Researchers have developed a more accurate method to discover and document pervasive “forever” chemicals, which have been found in the blood of people and other animals across the globe.
IonSense, maker of the DART ionisation technology, has been acquired by Bruker. The deal provides financial investments to ramp up development of the DART technology.
An innovative sample preparation method for cellular proteomics and protein structural analysis improves the removal of SDS.
Newomics Inc. and Bruker Corporation have announced collaborations on a novel LC-MS platform for drug discovery in the pharma/biopharma industry as well as research institutions.
NASA has opened a competition to anyone to build a model to automatically analyse mass spectrometry data collected for Mars exploration.
Agilent will integrate the AI technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis.
2022 marks Hiden Analytical’s 40th year of continuous and independent operation in the field of mass spectrometry.
Waters has acquired the technology assets and intellectual property rights of Megadalton Solutions, a developer of charge detection mass spectrometry.
Researchers from the Medical University of South Carolina have used mass spectrometry imaging to study the efficacy and distribution of injected biomaterials for the treatment of heart attack.